BCL2 and acute lymphoblastic leukemia: An investigation of in vitro models revealed that Ven killed B-ALL cell lines and primary cells by inhibiting cell proliferation, inducing cell cycle arrest and inducing apoptosis, and the expression level of BCL-2 was closely related to the antileukemic effects of Ven on B-ALL cell lines (11).